Expression of MT-3 protein in the human kidney.

[1]  S. Garrett,et al.  Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma. , 1997, Toxicology letters.

[2]  P. Fraser,et al.  Sensitive detection of metallothioneins-1, -2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention. , 1996, Journal of biochemical and biophysical methods.

[3]  D. Sens,et al.  Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. , 1996, Toxicology letters.

[4]  C. Klaassen,et al.  Effect of several metallothionein inducers on oxidative stress defense mechanisms in rats. , 1995, Toxicology.

[5]  P. Pauwels,et al.  Modulation of metallothionein-III mRNA content and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes. , 1995, Biochemical and biophysical research communications.

[6]  R. Palmiter,et al.  Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. , 1995, Biochemistry.

[7]  N. Imura,et al.  Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. , 1994, Cancer research.

[8]  P. Predki,et al.  Metal replacement in "zinc finger" and its effect on DNA binding. , 1994, Environmental health perspectives.

[9]  F. Stennard,et al.  Characterisation of six additional human metallothionein genes. , 1994, Biochimica et biophysica acta.

[10]  R. Palmiter,et al.  Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF) , 1994, Brain Research.

[11]  R. Palmiter,et al.  Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. , 1994, Biochemistry.

[12]  Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry. , 1993 .

[13]  鈴木 和夫,et al.  Metallothionein III : biological roles and medical implications , 1993 .

[14]  S. Tsuji,et al.  Molecular cloning of human growth inhibitory factor cDNA and its down‐regulation in Alzheimer's disease. , 1992, The EMBO journal.

[15]  R. Palmiter,et al.  MT-III, a brain-specific member of the metallothionein gene family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Titani,et al.  The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein , 1991, Neuron.

[17]  C. E. Hildebrand,et al.  Human metallothionein genes: structure of the functional locus at 16q13. , 1990, Genomics.

[18]  J. Kägi,et al.  Chemistry and biochemistry of metallothionein. , 1987, Experientia. Supplementum.

[19]  Diponkar Banerjee,et al.  IMMUNOHISTOCHEMICAL LOCALIZATION OF METALLOTHIONEIN IN CELL NUCLEUS AND CYTOPLASM OF FETAL HUMAN LIVER AND KIDNEY AND ITS CHANGES DURING DEVELOPMENT , 1987, Pathology.

[20]  C. Klaassen,et al.  Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality. , 1983, Toxicology and applied pharmacology.

[21]  M. Panemangalore,et al.  Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. , 1983, Developmental biology.

[22]  Y. Hamashima,et al.  IMMUNOHISTOLOGICAL STUDIES OF METALLOTHIONEIN , 1980 .

[23]  A. Leber,et al.  A mechanism for cadmium- and zinc-induced tolerance to cadmium toxicity: involvement of metallothionein. , 1976, Toxicology and applied pharmacology.